Search
Indaptus Therapeutics Inc
INDPAdd to Watchlist
1.290USD
-0.150-10.42%
Close 07-31 16:00（ET）Quotes delayed by 15 min
146.08MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31No earnings forecast score is currently available for Indaptus Therapeutics Inc. The Biotechnology & Medical Research industry's average is 8.14. The average price target is 10.00, with a high of 10.00 and a low of 10.00.
Analyst Rating
Based on
0
analysts
--
Current Rating
10.000
Target Price
+478.03%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Indaptus Therapeutics Inc
INDP
0
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
26
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Indaptus Therapeutics Inc's price target?
Analysts forecast that Indaptus Therapeutics Inc's price target is USD 10.00, with the highest forecast at USD 10.00 and the lowest forecast at USD 10.00.
How have Indaptus Therapeutics IncINDP's recent earnings per share performed?
The market expectation was USD -0.23, while Indaptus Therapeutics IncINDP's earnings per share (EPS) for the previous quarter was USD -4.51. EPS for the next quarter is expected at USD -1.57.